NCI Awards $8.3m for Clinical Trials Investigating HPV-Related Cancers in U.S. & Latin America
Three prominent research institutions—two in America and one in Brazil—received a 5-year, $8.3 million research grant from the National Cancer […]
University of Texas at Austin-Led Research Reveals 73% of Head & Neck Cancers are Related to HPV
University of Texas at Austin-led research discovers that 73% of head and neck cancers are related to human papillomavirus (HPV) […]
ULACNet to Conduct Clinical Trials to Determine if HPV Vaccine can Reduce HPV Cancer Risks for HIV Positive Men
A new National Cancer Institute (NCI) funded clinical trial will help investigators determine whether a HPV Vaccine known as “Gardasil […]
MD Anderson Launches Phase 2 HPV Vaccine Study Evaluating Combo Therapies
MD Anderson is launching a Phase 2 HPV vaccine study evaluating T cell-activating immunotherapy MEDI0457 with MedImmune’s durvalumab targeting several […]
University of Alabama Preclinical Evidence Suggests Cancer Drugs Can Treat HPVs
University of Alabama at Birmingham preclinical research results suggest that cancer drugs vorinostat, belinostat and panobinostat might be repurposed to […]
MD Anderson Immunotherapy Combo Promising for HPV-Related Cancers
Read Todd Ackerman’s piece in the Houston Chronicle about the combination of two therapies that enlist the patient’s immune system, […]
